Amidst discrepant SPRINT and ACCORD data, this study confirms the benefits seen in nondiabetics, Shawna Nesbitt says.
CHICAGO, IL—The weight-loss medication tirzepatide (Eli Lilly) significantly cut the risk of cardiovascular mortality and ...
Total and LDL cholesterol variability over time may be a biomarker for higher dementia risk and cognitive decline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback